A5020121873- Diabetes Management and Research
- Chronic Kidney Disease and Diabetes
- Diabetes Management and Education
- Blood Pressure and Hypertension Studies
- Dialysis and Renal Disease Management
- Diabetes Treatment and Management
Bayer (Germany)
2022-2024
Despite effective treatment options, chronic kidney disease (CKD) has become a major cause of mortality worldwide due to the ever-increasing number patients with type 2 diabetes mellitus (T2DM). Guideline-compliant, at least, annual screening T2DM is crucial prevent renal progression. However, data on prevalence CKD in and frequency are limited. SMART-Finder first study exclusively use provided directly by via an adherence app collect information CKD, risk factors, management, quality life...
<sec> <title>BACKGROUND</title> Chronic kidney disease (CKD) is a common comorbidity of type 2 diabetes mellitus (T2DM). Data on the determination CKD-related biomarkers in real-life setting patients with T2DM Germany are limited. </sec> <title>OBJECTIVE</title> We aimed to determine prevalence CKD and risk factors, availability urine albumin-to-creatinine ratio (UACR) estimated glomerular filtration rate (eGFR) values, treatment satisfaction, quality life Germany. <title>METHODS</title>...
Chronic kidney disease (CKD) is a common comorbidity of type 2 diabetes mellitus (T2DM). Data on the determination CKD-related biomarkers among patients with T2DM in real-life setting within Germany are limited. We aimed to determine prevalence CKD and risk factors, availability urine albumin-to-creatinine ratio (UACR) estimated glomerular filtration rate (eGFR) values, treatment satisfaction, quality life Germany. SMART-Finder retrospective prospective, observational, digital,...
<sec> <title>BACKGROUND</title> Despite effective treatment options, chronic kidney disease (CKD) has become a major cause of mortality worldwide due to the ever-increasing number patients with type 2 diabetes mellitus (T2DM). Guideline-compliant, at least, annual screening T2DM is crucial prevent renal progression. However, data on prevalence CKD in and frequency are limited. SMART-Finder first study exclusively use provided directly by via an adherence app collect information CKD, risk...